Gregory W. Gironda - Nov 1, 2022 Form 3 Insider Report for Odyssey Health, Inc. (ODYY)

Role: Chief Operating Officer
Signature: /s/ Christine M. Farrell, Attorney-in-Fact for Gregory W. Gironda
Stock symbol: ODYY
Transactions as of: Nov 1, 2022
Transactions value $: $0
Form type: 3
Date filed: 11/23/2022, 03:03 PM
Next filing: Jan 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ODYY	Stock Option - Right to Buy							Nov 1, 2022	Common Stock	75K	$0.20	Direct
holding	ODYY	Stock Option - Right to Buy							Nov 1, 2022	Common Stock	75K	$0.20	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	75,000 shares vest, upon the execution of an agreement between Company and a strategic partner related to Company's drug ONP-002, or upon the funding for a Phase II trial that comes from a source identified by Consultant for a minimum of five million dollars ($5,000,000) closed prior to the Term.